Fusicatenibacter saccharivorans

Information

Microbe Identification

Fusicatenibacter saccharivorans

Microbe id: PMDBM2020717
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Fusicatenibacter saccharivorans [1150298]
Taxonomy Genus: Fusicatenibacter [1407607]
Taxonomy Family: Lachnospiraceae [186803]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Fusicatenibacter saccharivorans

Identified MGC Region
(click for details)
MGC Cluster (Most Similar) Similarity Compound metabolized by the MGC Type of MGC Reference(PubMed ID)
Unclassified gene clusterN.a. / Amino acidsOthers HGD unassigned,TPP AA metabolismPMID: 36782070 / PMID: 36782070
Succinate to propionate A. sp. KLE1797SuccinateSuccinate to propionatePMID: 24553467
Acetyl-CoA pathway B. hydrogenotrophicaChemolithoautotrophic substrates such as CO and carbon dioxideAcetyl-CoA pathwayPMID: 27733845
Putrescine2spermidine E. rectalePutrescinePutrescine to spermidinePMID: 30183487
Rnf complex C. sporogenesEnergy-capturing-relatedRnf complexPMID: 23269825
Gallic acid degradation B. sp. KLEGallic acidGallic acid metPMID: 30054365
PFOR II pathway B. thetaiotaomicronPyruvatePFOR II pathwayPMID: 32301184

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Fusicatenibacter saccharivorans


Identified BGC Region
(click for details)
BGC Cluster (Most Similar) Similarity Compound Synthesized by the BGC Type of BGC Reference (PubMed ID)
Unclassified gene clustern.a.RanthipeptidePMID: 34019648
Unclassified gene clustern.a.RanthipeptidePMID: 34019648
Unclassified gene clustern.a.RRE-containingPMID: 34019648
Unclassified gene clustern.a.RRE-containingPMID: 34019648
Unclassified gene clustern.a.Cyclic-lactone-autoinducerPMID: 34019648

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Fusicatenibacter saccharivorans distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Fusicatenibacter saccharivorans in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Fusicatenibacter saccharivorans

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗-3.79626881015326mNGS
Kidney Failure, Chronic PRJNA449784🔗3.27566812190025mNGS
Hemangioma, Cavernous PRJNA629755🔗-3.39420646954729mNGS
Hypertension PRJNA509999🔗-3.17107309668207mNGS
Diarrhea PRJEB14038🔗-4.05155947642039mNGS
Colorectal Neoplasms PRJNA1167935🔗-3.73495312036638mNGS
Colorectal Neoplasms PRJNA961076🔗-3.57135930746289mNGS
Colorectal Neoplasms PRJEB70916🔗-3.48703143474134mNGS
Colorectal Neoplasms PRJNA731589🔗-3.4309097762235mNGS
Colorectal Neoplasms PRJNA1138893🔗-3.34123628920391mNGS
Colorectal Neoplasms PRJEB53891🔗-3.3142587853584mNGS
Colorectal Neoplasms PRJNA888860🔗-3.06212772712822mNGS
Colorectal Neoplasms PRJNA763023🔗-2.51063307809104mNGS
Parkinson Disease PRJEB59350🔗-3.5399645582096mNGS
Colitis, Ulcerative PRJNA993675🔗-3.74125974279649mNGS
Colitis, Ulcerative PRJNA983946🔗-3.58936541230095mNGS
Colitis, Ulcerative PRJNA429990🔗-3.37677655812628mNGS
Colitis, Ulcerative PRJNA398089🔗3.11601189509667mNGS
Carcinoma, Hepatocellular PRJNA932948🔗-3.75503974736547mNGS
Psychotic Disorders PRJNA1044118🔗-4.35594773005498mNGS
Prostatic Neoplasms PRJNA769284🔗-4.01846945855593mNGS
Schizophrenia PRJNA1135717🔗-3.46255650059283mNGS
Crohn Disease PRJNA813736🔗-4.08756181096357mNGS
Crohn Disease PRJNA993675🔗-3.7883116902464mNGS
Crohn Disease PRJNA429990🔗-3.35875292945638mNGS
Crohn Disease PRJNA793776🔗-3.17244661331259mNGS
Crohn Disease PRJNA398089🔗3.18392646709544mNGS
Arthritis, Rheumatoid PRJNA896336🔗3.96066572165516mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-2.92058975476438mNGS
Anorexia PRJNA674716🔗-3.54430441653023mNGS
Central Serous Chorioretinopathy PRJEB38997🔗-3.80210832271911mNGS
Neuroblastoma PRJEB63351🔗-3.66264224467957mNGS
Myasthenia Gravis PRJNA688881🔗-3.23969765805483mNGS
Depressive Disorder, Major PRJNA762199🔗-3.80606247094832mNGS
Gastroesophageal Reflux PRJNA993632🔗-4.6847557878315mNGS
Clostridium Infections PRJNA648321🔗-4.17824995244339mNGS
Cholelithiasis PRJNA999028🔗-4.05482628057215mNGS
Autism Spectrum Disorder PRJNA686821🔗-4.28921115740288mNGS
Inflammatory Bowel Diseases PRJNA511372🔗-4.05852587501211mNGS
Inflammatory Bowel Diseases PRJNA993675🔗-3.9155621080393mNGS
Biliary Atresia PRJNA730640🔗-4.30536226341377mNGS
Renal Insufficiency, Chronic PRJEB65297🔗-3.83477501335272mNGS
Fibromyalgia PRJEB80379🔗-4.36720799553425mNGS
COVID-19 PRJDB13214🔗-4.17817765567111mNGS
COVID-19 PRJNA624223🔗-4.05837884694298mNGS
COVID-19 PRJNA689961🔗-3.75381583532283mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Fusicatenibacter saccharivorans



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Fusicatenibacter saccharivorans



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Fusicatenibacter saccharivorans

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
1Fusicatenibacter_saccharivorans_ERR1022307 Download
2Fusicatenibacter_saccharivorans_ERR1022400 Download
3Fusicatenibacter_saccharivorans_ERR1022437 Download

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Fusicatenibacter saccharivorans


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Fusicatenibacter saccharivorans



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Fusicatenibacter saccharivorans

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Fusicatenibacter saccharivorans

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Fusicatenibacter saccharivorans

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found!

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Fusicatenibacter saccharivorans



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Fusicatenibacter saccharivorans


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Fusicatenibacter saccharivorans


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?